Skip to content Skip to footer
PharmaShots Interview Medicago’s Brian Ward Shares Insights on COVIFENZ, a Plant-Based COVID-19 Vaccine

PharmaShots Interview: Medicago’s Brian Ward Shares Insights on COVIFENZ, a Plant-Based COVID-19 Vaccine

In an interview with PharmaShots, Brian Ward, CEO at Medicago shared his views on the approval of a Plant-Based COVID-19 Vaccine in combination with GSK’s pandemic adjuvantShots:Brian talked about the data that supported the approval of Medicago’s plant-based Covid-19 vaccine by Health CanadaHe focused on the safety and efficacy of the vaccine…

Read more